Is Skipping Dinner the Next Big Thing in Intermittent Fasting?
Is Skipping Dinner the Next Big Thing in Intermittent Fasting?
Is Skipping Dinner the Next Big Thing in Intermittent Fasting?
Skipping dinner, often called dinner cancelling, has grown in popularity as a simple form of intermittent fasting. The approach extends the body's natural overnight fasting window, with potential benefits for metabolism and long-term health. But while short-term effects look promising, experts warn that research on its impact—especially for people with type 2 diabetes—remains limited and inconclusive.
The key to dinner cancelling lies in the length of the fasting period. A 14- to 16-hour window is common, often achieved by finishing the last meal in the early afternoon. Within a few hours of eating, insulin levels drop, and the body begins tapping into stored energy reserves. After around 14 hours without food, autophagy—the body's cellular recycling process—kicks in, aiding repair and reducing inflammation.
Certain habits can support these fasting effects. Light exercise, along with foods like turmeric or chilli, may enhance the body's natural processes during fasting. However, mistakes can disrupt the benefits. Protein-rich snacks, for example, can break the fast and halt metabolic shifts.
Studies from 2023 to 2025 suggest short-term advantages, such as better blood sugar control and weight loss in people with type 2 diabetes. Yet, as of 2026, no large-scale reviews or long-term trials exist. Small studies hint at lower HbA1c levels, but experts stress the need for rigorous research—particularly on cardiovascular risks and whether the practice remains safe and effective beyond a year.
Even occasional fasting windows may improve metabolism, lower blood pressure, and slow cellular ageing. The exact effects depend on how long the fast lasts and what was eaten beforehand.
Dinner cancelling offers a straightforward way to extend fasting, with early evidence pointing to metabolic and health benefits. However, long-term impacts—especially for those with type 2 diabetes—stay uncertain due to limited research. For now, the approach remains an option worth watching, but not one fully backed by extensive scientific trials.